Current literature indicates that people with severe mental illness have higher mortality rates than the general population, with the most common cause being increased rates of cardiovascular disease. Unfortunately, despite national metabolic screening guidelines, people taking antipsychotic medications are unlikely to receive metabolic screening, which likely contributes to excess cardiovascular mortality. Given the significant disparities in health care received by people with severe mental illness, any effort to improve the quality of medical care of this highly vulnerable population are extremely important. Improving metabolic screening rates in people with severe mental illness will increase early detection and treatment, thereby reducing premature mortality rates. Below are some of the studies underway in PReMIUM to reduce this health care disparity.

- CRANIUM

- CalMEND Data

- DISCO

- HEALTH